Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: OFIX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.8
1 Year Target Price $22.8
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.57% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 629.63M USD | Price to earnings Ratio - | 1Y Target Price 22.8 |
Price to earnings Ratio - | 1Y Target Price 22.8 | ||
Volume (30-day avg) 5 | Beta 0.82 | 52 Weeks Range 10.24 - 20.48 | Updated Date 12/5/2025 |
52 Weeks Range 10.24 - 20.48 | Updated Date 12/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.56% | Operating Margin (TTM) -8.35% |
Management Effectiveness
Return on Assets (TTM) -5.69% | Return on Equity (TTM) -24.6% |
Valuation
Trailing PE - | Forward PE 37.88 | Enterprise Value 772048571 | Price to Sales(TTM) 0.77 |
Enterprise Value 772048571 | Price to Sales(TTM) 0.77 | ||
Enterprise Value to Revenue 0.94 | Enterprise Value to EBITDA 146.67 | Shares Outstanding 39599659 | Shares Floating 39113771 |
Shares Outstanding 39599659 | Shares Floating 39113771 | ||
Percent Insiders 2.4 | Percent Institutions 91.46 |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980 in Verona, Italy, and later relocated its headquarters to Lewisville, Texas, USA. The company initially focused on spinal and orthopedic implants. Key milestones include its initial public offering (IPO) in 1991 and numerous product innovations and strategic acquisitions over the decades, expanding its global presence and product portfolio in orthopedic and spine solutions.
Core Business Areas
- Spine: Designs, manufactures, and markets a comprehensive portfolio of spinal products for fusion, motion preservation, and minimally invasive surgery. This includes implants, biologics, and instrumentation for treating a wide range of spinal pathologies.
- Orthopedics: Offers a broad range of orthopedic products for limb and joint reconstruction, trauma, and extremity applications. This includes external fixation devices, intramedullary nails, and joint replacement components.
- Regenerative Medicine: Focuses on developing and commercializing advanced biological solutions to enhance bone healing and regeneration. This segment includes bone graft substitutes and growth factors.
Leadership and Structure
Orthofix Medical Inc. is led by a seasoned executive team with expertise in the medical device industry. The company operates through a divisional structure aligned with its core business areas, supported by global sales, marketing, research and development, and manufacturing operations.
Top Products and Market Share
Key Offerings
- Spinal Fusion Systems: Offers a range of interbody devices, pedicle screw systems, and fixation implants for spinal fusion procedures across the cervical, thoracic, and lumbar spine. Competitors include Medtronic, Johnson & Johnson (DePuy Synthes), Stryker, and Zimmer Biomet.
- External Fixation Systems: Specializes in advanced external fixation devices for complex trauma, limb lengthening, and deformity correction. Competitors include Stryker, Smith+Nephew, and Acumed.
- Orthobiologics: Provides bone graft substitutes and other biological solutions to promote bone healing in orthopedic and spine procedures. Key competitors include Medtronic, NuVasive, and Zimmer Biomet.
Market Dynamics
Industry Overview
The orthopedic and spine market is a dynamic and growing sector driven by an aging global population, increasing prevalence of degenerative diseases, advancements in medical technology, and a rising demand for minimally invasive procedures. The market is characterized by intense competition, stringent regulatory requirements, and a focus on innovation and evidence-based outcomes.
Positioning
Orthofix Medical Inc. is positioned as a focused global orthopedics company offering innovative solutions in spine, orthopedics, and regenerative medicine. Its competitive advantages lie in its specialized product portfolio, commitment to innovation, and a strong global commercial infrastructure. The company aims to differentiate itself through its ability to address complex orthopedic challenges.
Total Addressable Market (TAM)
The global orthopedic and spine market is a multi-billion dollar industry. While specific TAM figures vary by segment, it is estimated to be in the hundreds of billions of dollars, with steady growth projected. Orthofix Medical Inc. targets specific niches within this market, aiming to capture significant share through its specialized offerings.
Upturn SWOT Analysis
Strengths
- Specialized product portfolio in spine and orthopedics.
- Commitment to innovation and R&D.
- Global commercial presence and distribution network.
- Expertise in external fixation and regenerative medicine.
Weaknesses
- Relatively smaller scale compared to larger diversified medical device companies.
- Dependence on key product lines.
- Potential challenges in integrating acquired businesses.
Opportunities
- Growing demand for minimally invasive orthopedic procedures.
- Expansion into emerging markets.
- Development of new biologic and digital health solutions.
- Strategic acquisitions to broaden product offerings and market reach.
Threats
- Intense competition from larger and smaller players.
- Pricing pressures and reimbursement challenges.
- Regulatory hurdles and compliance requirements.
- Potential for disruptive technologies.
Competitors and Market Share
Key Competitors
- Medtronic plc (MDT)
- Johnson & Johnson (JNJ)
- Stryker Corporation (SYK)
- Zimmer Biomet Holdings, Inc. (ZBH)
- NuVasive, Inc. (NUVA)
Competitive Landscape
Orthofix faces formidable competition from larger, more diversified players with extensive R&D budgets and established market dominance. Its advantage lies in its agility and focus on specific niches within the orthopedic and spine market. The company must continually innovate and execute its strategy effectively to gain market share and differentiate itself.
Major Acquisitions
SeaSpine Holdings Corporation
- Year: 2023
- Acquisition Price (USD millions): 1.1
- Strategic Rationale: To significantly enhance Orthofix's spine business by combining complementary portfolios, expanding product offerings, and creating a more robust spine franchise.
Enovis Corporation's Joint Replacement Business
- Year: 2021
- Acquisition Price (USD millions): 100
- Strategic Rationale: To expand Orthofix's presence in the growing joint replacement market and complement its existing orthopedic portfolio.
Growth Trajectory and Initiatives
Historical Growth: Orthofix has experienced significant revenue growth, particularly in 2022, driven by strong performance in its spine segment and strategic acquisitions. However, profitability has been impacted by integration costs and operational expenses.
Future Projections: Analyst consensus suggests continued revenue growth driven by product innovation and market expansion. Profitability is expected to improve as integration efforts mature and operational efficiencies are realized. Specific growth projections vary by analyst and depend on the successful execution of strategic initiatives.
Recent Initiatives: Acquisition of SeaSpine Holdings Corporation (completed in 2023) to strengthen its spine portfolio.,Continued investment in R&D to develop next-generation orthopedic and spine solutions.,Focus on expanding its global commercial footprint.
Summary
Orthofix Medical Inc. is a focused orthopedic and spine company with strong growth potential driven by strategic acquisitions and product innovation. While revenue has seen significant increases, profitability has been challenged by integration costs. The company's success hinges on its ability to effectively integrate acquired businesses, drive organic growth in its core segments, and navigate a highly competitive market. Continued investment in R&D and operational efficiency will be crucial for long-term success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Orthofix Medical Inc. Investor Relations
- Company Annual Reports (10-K)
- Quarterly Reports (10-Q)
- Financial News Outlets (e.g., Wall Street Journal, Bloomberg)
- Industry Analysis Reports
Disclaimers:
This JSON output is generated for informational purposes only and does not constitute financial advice. Data accuracy is subject to the availability and reliability of the provided sources. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO & Director Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.